Latest Regulatory News

Lake Resources N.L. has upgraded its Kachi lithium brine resource in Argentina, increasing the Measured and Indicated lithium carbonate equivalent to 8.2 million tonnes, supported by new drilling data and enhanced lithium recovery technology.

Vinyl Group has applied to the Federal Court for an extension to lodge delayed cleansing notices, aiming to lift its ASX trading suspension. The court hearing is set for 5 June 2025, with market watchers awaiting the outcome.

Magnum Mining and Exploration Limited has announced a pro-rata entitlement offer to raise up to $2.24 million, aiming to fund key exploration projects across Brazil, the US, and Nevada. The offer carries significant dilution risks for non-participating shareholders and underscores ongoing operational uncertainties.

Magnum Mining and Exploration has initiated a $2.2 million entitlement offer at a significant discount, aiming to strengthen its capital base and fund key projects in Australia and the US.

Robex Resources Inc., a Canadian gold explorer and producer with key assets in West Africa, has launched a fully underwritten initial public offering (IPO) on the ASX to raise A$120 million. The capital will primarily support the development of its advanced Kiniero Gold Project in Guinea, alongside ongoing operations at the Nampala Mine in Mali.

InhaleRx has secured swift Human Research Ethics Committee approval for its redesigned IRX-211 Phase 2 trial, expanding participant numbers and potentially bypassing Phase 3 to speed market entry.

Manuka Resources is poised to restart silver production at its Wonawinta Mine targeting 13.2 million ounces, while progressing its large-scale vanadium-titanium-magnetite project in New Zealand with a robust $1.26 billion valuation.

Tasmea Limited has announced a fully franked special dividend of AUD 0.12 per share, payable on 30 June 2025, alongside a Dividend Reinvestment Plan offering a 5% discount on new shares.

High-Tech Metals Limited has successfully completed a modest capital raise through a non-renounceable entitlement offer, issuing shares at $0.15 each alongside free attaching options. The company now holds discretion over a significant shortfall placement, which could influence its capital structure in the coming months.

Recce Pharmaceuticals has completed a A$15.8 million capital raise to fund pivotal Phase 3 clinical trials and progress its FDA application, positioning the company for potential commercial breakthroughs in antibiotic-resistant infections.

Western Yilgarn NL has secured the Cardea 3 Bauxite Project in Western Australia's Darling Range, adding a significant high-grade bauxite asset near its Julimar Project. Historical drilling confirms strong alumina grades and strategic infrastructure access.

Tambourah Metals Ltd has announced a non-renounceable pro-rata entitlement offer to raise approximately $368,000, issuing new shares at $0.02 each with free-attaching options. The capital raise aims to fund exploration projects including Beatty Park Gold and Speewah North.